Ogiya, Rin http://orcid.org/0000-0002-0619-2838
Niikura, Naoki http://orcid.org/0000-0001-6732-8527
Kumamaru, Hiraku
Takeuchi, Yoshinori
Okamura, Takuho
Kinoshita, Takayuki
Aogi, Kenjiro
Anan, Keisei
Iijima, Kotaro
Ishida, Takanori
Iwamoto, Takayuki
Kawai, Masaaki
Kojima, Yasuyuki
Sakatani, Takashi
Sagara, Yasuaki
Hayashi, Naoki
Masuoka, Hideji
Yoshida, Masayuki
Miyata, Hiroaki
Tsuda, Hitoshi
Imoto, Shigeru
Jinno, Hiromitsu
Funding for this research was provided by:
the Japanese Breast Cancer Society (17003)
Article History
Received: 7 March 2020
Accepted: 8 August 2020
First Online: 20 August 2020
Compliance with ethical standards
:
: Dr. Ogiya, Dr. Aogi, Dr. Kinoshita, Dr. Iwamoto, Dr. Jinno, Dr. Kawai, Dr. Okamura, Dr. Takeuchi, Dr. Yoshida, Dr. Imoto, Dr. Masuoka, Dr. Sagara, and Dr. Kojima have nothing to disclose. Dr. Niikura reports grants from Novartis, Bristol-Myers Squibb, Chugai Pharmaceutical Co, Nihon Medi-Physics Co. Ltd., Merc Sharp & Dohme, Daiichi-Sankyo (RF-to Tokai University), and personal fees from AstraZeneca, Novartis, Eisai, and Pfizer; Dr. Ishida reports grants from Taiho Pharmaceutical Co., Ltd, Eisai, Kyowa-Kirin, Chugai Pharmaceutical co., Ltd., personal fees from Chugai Pharmaceutical co., Ltd., Pfizer Japan Inc., and Eisai Co., Ltd. Dr. Hayashi reports personal fees from Chugai-pharma, Novartis, AstraZeneca, Pfizer, Kirin Pharma, Genomic Health Inc., Devicor Japan, and Allergan Japan. Dr. Anan reports personal fees from Pfizer, Chugai Pharmaceutical, AstraZeneca, Eisai, Novartis Pharma, and Eli Lilly. Dr. Tsuda reports grants from Taiho Pharmaceutical Co. and Chugai Pharmaceutical Co., grants and personal fees from Roche Diagnostics Co., and personal fees from Konica Minolta Co., Eisai Co., AstraZeneca, and Bristol-Myers Squibb. Dr. Miyata and Dr. Kumamaru report being affiliated with the department of healthcare quality assessment at the University of Tokyo. The department is a social collaboration department supported by the National Clinical Database, Johnson & Johnson K.K., and Nipro Corporation.
: This article does not contain any studies involving human participants performed by any of the authors.